Investors
Investcorp Struggling to Sell Armacell
Armacell bids well below base price set by Investcorp. The sale of Armacell is creating issues as Investocorp's base price could not be reached by the existing bidders.
Affymax Continues Tumble
Affymax's drug recall Ormontys caused decline of the company. Pharmaceutical firm Affymax continued its decline after it fired nearly three fourths of its labor complement and is now in the process of opting for a sale or declaration of bankruptcy.
Pyramid Analytics Supported by Sequoia Capital
Sequoia Capital leads capital funding for Pyramid Analytics. The premiere company that provides data driven decision making to end users at all levels has announces the closure of its latest funding round.
Complete Genomics Acquired by BGI-Shenzhen
BGI-Shenzhen acquires Complete Genomics after regulatory approvals from China and the US were obtained.